94 related articles for article (PubMed ID: 31682980)
1. Azithromycin Use and Increased Cancer Risk among Patients with Bronchiolitis Obliterans after Hematopoietic Cell Transplantation.
Cheng GS; Bondeelle L; Gooley T; He Q; Jamani K; Krakow EF; Flowers MED; de Latour RP; Michonneau D; Socié G; Chien JW; Chevret S; Bergeron A
Biol Blood Marrow Transplant; 2020 Feb; 26(2):392-400. PubMed ID: 31682980
[TBL] [Abstract][Full Text] [Related]
2. Severity of Chronic Graft-versus-Host Disease and Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancy.
Lee CJ; Wang T; Chen K; Arora M; Brazauskas R; Spellman SR; Kitko C; MacMillan ML; Pidala JA; Badawy SM; Bhatt N; Bhatt VR; DeFilipp Z; Diaz MA; Farhadfar N; Gadalla S; Hashmi S; Hematti P; Hossain NM; Inamoto Y; Lekakis LJ; Sharma A; Solomon S; Lee SJ; Couriel DR
Transplant Cell Ther; 2024 Jan; 30(1):97.e1-97.e14. PubMed ID: 37844687
[TBL] [Abstract][Full Text] [Related]
3. Proteomic Characterization Reveals That MMP-3 Correlates With Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell and Lung Transplantation.
Liu X; Yue Z; Yu J; Daguindau E; Kushekhar K; Zhang Q; Ogata Y; Gafken PR; Inamoto Y; Gracon A; Wilkes DS; Hansen JA; Lee SJ; Chen JY; Paczesny S
Am J Transplant; 2016 Aug; 16(8):2342-51. PubMed ID: 26887344
[TBL] [Abstract][Full Text] [Related]
4. A Nasal Inflammatory Cytokine Signature Is Associated with Early Graft-versus-Host Disease of the Lung after Allogeneic Hematopoietic Cell Transplantation: Proof of Concept.
Ostrin EJ; Rider NL; Alousi AM; Irajizad E; Li L; Peng Q; Kim ST; Bashoura L; Arain MH; Noor LZ; Patel N; Mehta R; Popat UR; Hosing C; Jenq RR; Rondon G; Hanash SM; Paczesny S; Shpall EJ; Champlin RE; Dickey BF; Sheshadri A
Immunohorizons; 2023 Jun; 7(6):421-430. PubMed ID: 37289498
[TBL] [Abstract][Full Text] [Related]
5. Early and rapid development of bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation.
Dickey JS; Dickey BF; Alousi AM; Champlin RE; Sheshadri A
Respir Med Case Rep; 2024; 49():102001. PubMed ID: 38745870
[TBL] [Abstract][Full Text] [Related]
6. Surfactant protein D is associated with pulmonary manifestations of chronic graft-versus-host disease following hematopoietic stem cell transplantation.
Krarup AM; Kielsen K; Uhlving HH; Steffensen R; Sørum ME; Nielsen KG; Buchvald FF; Sorensen GL; Müller KG
Pediatr Pulmonol; 2024 Apr; 59(4):1103-1107. PubMed ID: 38206069
[No Abstract] [Full Text] [Related]
7. Clinical risk factors and prognostic model for patients with bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
Huang QS; Han TX; Chen Q; Wu J; Zhao P; Wu YJ; He Y; Zhu XL; Fu HX; Wang FR; Zhang YY; Mo XD; Han W; Yan CH; Wang JZ; Chen H; Chen YH; Han TT; Lv M; Chen Y; Wang Y; Xu LP; Liu KY; Huang XJ; Zhang XH
Bone Marrow Transplant; 2024 Feb; 59(2):239-246. PubMed ID: 38012449
[TBL] [Abstract][Full Text] [Related]
8. Early Post-Transplantation Spirometry Is Associated with the Development of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplantation.
Jamani K; He Q; Liu Y; Davis C; Hubbard J; Schoch G; Lee SJ; Gooley T; Flowers MED; Cheng GS
Biol Blood Marrow Transplant; 2020 May; 26(5):943-948. PubMed ID: 31821885
[TBL] [Abstract][Full Text] [Related]
9. Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation.
Penack O; Marchetti M; Ruutu T; Aljurf M; Bacigalupo A; Bonifazi F; Ciceri F; Cornelissen J; Malladi R; Duarte RF; Giebel S; Greinix H; Holler E; Lawitschka A; Mielke S; Mohty M; Arat M; Nagler A; Passweg J; Schoemans H; Socié G; Solano C; Vrhovac R; Zeiser R; Kröger N; Basak GW
Lancet Haematol; 2020 Feb; 7(2):e157-e167. PubMed ID: 32004485
[TBL] [Abstract][Full Text] [Related]
10. Risk of relapse in patients receiving azithromycin after allogeneic HSCT.
Kutzke JL; Merten JA; Taraba JL; Mara KC; Shah MV; Hashmi SK; Patnaik MM; Litzow MR; Hogan WJ; Alkhateeb HB
Bone Marrow Transplant; 2021 Apr; 56(4):960-962. PubMed ID: 33130820
[TBL] [Abstract][Full Text] [Related]
11. Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation.
Vallet N; Le Grand S; Bondeelle L; Hoareau B; Corneau A; Bouteiller D; Tournier S; Derivry L; Bohineust A; Tourret M; Gibert D; Mayeur E; Itzykson R; Pacchiardi K; Ingram B; Cassonnet S; Lepage P; Peffault de Latour R; Socié G; Bergeron A; Michonneau D
Blood; 2022 Dec; 140(23):2500-2513. PubMed ID: 35984904
[TBL] [Abstract][Full Text] [Related]
12. Macrolides for the prevention and treatment of feeding intolerance in preterm low birth weight infants: a systematic review and meta-analysis.
Basu S; Smith S
Eur J Pediatr; 2021 Feb; 180(2):353-378. PubMed ID: 33044576
[TBL] [Abstract][Full Text] [Related]
13. Systematic review and meta-analysis of treating meibomian gland dysfunction with azithromycin.
Tao T; Tao L
Eye (Lond); 2020 Oct; 34(10):1797-1808. PubMed ID: 32346111
[TBL] [Abstract][Full Text] [Related]
14. Macrolide antibiotics activate the integrated stress response and promote tumor proliferation.
Yu X; Tian AL; Wang P; Li J; Wu J; Li B; Liu Z; Liu S; Gao Z; Sun S; Sun S; Tu Y; Wu Q
Cell Stress; 2023 Apr; 7(4):20-33. PubMed ID: 37021084
[TBL] [Abstract][Full Text] [Related]
15. Diet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatment.
Schwabkey ZI; Wiesnoski DH; Chang CC; Tsai WB; Pham D; Ahmed SS; Hayase T; Ortega Turrubiates MR; El-Himri RK; Sanchez CA; Hayase E; Frenk Oquendo AC; Miyama T; Halsey TM; Heckel BE; Brown AN; Jin Y; Raybaud M; Prasad R; Flores I; McDaniel L; Chapa V; Lorenzi PL; Warmoes MO; Tan L; Swennes AG; Fowler S; Conner M; McHugh K; Graf T; Jensen VB; Peterson CB; Do KA; Zhang L; Shi Y; Wang Y; Galloway-Pena JR; Okhuysen PC; Daniel-MacDougall CR; Shono Y; Burgos da Silva M; Peled JU; van den Brink MRM; Ajami N; Wargo JA; Reddy P; Valdivia RH; Davey L; Rondon G; Srour SA; Mehta RS; Alousi AM; Shpall EJ; Champlin RE; Shelburne SA; Molldrem JJ; Jamal MA; Karmouch JL; Jenq RR
Sci Transl Med; 2022 Nov; 14(671):eabo3445. PubMed ID: 36383683
[TBL] [Abstract][Full Text] [Related]
16. [Chinese consensus on diagnosis and treatment of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation (2022)].
;
Zhonghua Xue Ye Xue Za Zhi; 2022 Jun; 43(6):441-447. PubMed ID: 35968585
[No Abstract] [Full Text] [Related]
17. Bronchiolitis obliterans syndrome after lung or haematopoietic stem cell transplantation: current management and future directions.
Glanville AR; Benden C; Bergeron A; Cheng GS; Gottlieb J; Lease ED; Perch M; Todd JL; Williams KM; Verleden GM
ERJ Open Res; 2022 Jul; 8(3):. PubMed ID: 35898810
[TBL] [Abstract][Full Text] [Related]
18. Effect of azithromycin on bronchiolitis obliterans syndrome in posttransplant recipients: A systematic review and meta-analysis.
Hao X; Peng C; Lian W; Liu H; Fu G
Medicine (Baltimore); 2022 Jul; 101(28):e29160. PubMed ID: 35839027
[TBL] [Abstract][Full Text] [Related]
19. A Gut Instinct on Leukaemia: A New Mechanistic Hypothesis for Microbiota-Immune Crosstalk in Disease Progression and Relapse.
Pagani IS; Poudel G; Wardill HR
Microorganisms; 2022 Mar; 10(4):. PubMed ID: 35456764
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
